GL1X · GenesisL1 explorer

MolNFT v1 · #170482 · protein

Structure of full-length CD20 in complex with rituximab Fab

6Y90: “Structure of full-length CD20 in complex with rituximab Fab”. Electron microscopy, 3 ligands (MYS, Y01, PC1). MolNFT v1 #170482 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6Y90
Type
protein
Length
1,218 residues
Chains
6
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P11836
Ligands
MYS, Y01, PC1

Structure

electron microscopy · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein172—P11836
C, H—protein224——
D, L—protein213——

Ligands and binding sites

  • MYS · Pentadecane · ligand · 10 copies · chains A, B
  • Y01 · Cholesterol hemisuccinate · ligand · 8 copies · chains A, B
  • PC1 · 1,2-diacyl-sn-glycero-3-phosphocholine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6Y90 · Structure of full-length CD20 in complex with Rituximab Fab · the same entry in another collection · chain L against L, TM-score 1.00
  • P11836 · AlphaFold monomer V2.0 prediction for B-lymphocyte antigen CD20 (P11836) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.